What's new? Log in Free sign up

Bioceres Crop Solutions (BIOX)

Company Profile

Company profile

Ticker

BIOX

Exchange

Website

biocerescrops.com

CEO

Dr. Federico Trucco Ph.D.

Incorporated

Location

Fiscal year end

Sector

Manufacturing > Pesticide and Other Agricultural Chemical Manufacturing

Industry (SIC)

Agricultural Chemicals

The Mosaic Company • CF Industries • The Scotts Miracle-Gro Company • Audacy • CVR Partners • American Vanguard • Enlightify • Marrone Bio Innovations • Cibus • Muliang Viagoo Technology ...

Former names

Olivia Ventures, Inc.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

BIOX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$10.75

Low target

$9.50

High target

$12.00

Canaccord Genuity

Latest filings (excl ownership)

View all

Prospectus supplement

Notice of effectiveness

Shelf registration (foreign) (amended)

Shelf registration (foreign)

Current report (foreign)

Current report (foreign)

Current report (foreign)

Annual report (foreign)

30 Oct 24

Current report (foreign)

Current report (foreign)

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Fourth Sail Capital LP

Bioceres Group PLC

Bioceres Group PLC

Solel Partners LP

Solel Partners LP

ARDSLEY ADVISORY PARTNERS LP

DRACO Capital Investment Management Co Ltd

DRACO Capital Investment Management Co Ltd

Financial summary

Financial statements Chart BIOX financial data

Quarter (USD)	Jun 24	Jun 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 24	Jun 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

BIOX institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	22	54	-59.3%
Opened positions	4	46	-91.3%
Closed positions	36	1	+3500.0%
Increased positions	4	1	+300.0%
Reduced positions	1	1	–

13F shares	Current	Prev Q	Change
Total value	28.98 bn	145.11 bn	-80.0%
Total shares	79.52 mm	88.96 mm	-10.6%
Total puts	0.00	6.40 k	EXIT
Total calls	0.00	47.20 k	EXIT
Total put/call ratio	–	0.1	–

Largest owners	Shares	Value	Change
Bioceres	31.56 mm	$440.90 mm	0.0%
Bioceres	30.83 mm	$394.94 mm	0.0%
5D+ Capital Investment Management	8.16 mm	$115.37 mm	0.0%
Ospraie Ag Science	6.23 mm	$58.85 mm	0.0%
Fourth Sail Capital	1.96 mm	$21.99 bn	+20.5%
DRACO Capital Investment Management	215.00 k	$3.00 mm	0.0%
PNC The PNC Financial Services Group, Inc.	150.00 k	$1.68 bn	0.0%
Albert D Mason	66.98 k	$750.82 mm	+0.3%
Oak Family Advisors	64.93 k	$727.81 mm	+1.9%
Dimensional Fund Advisors	61.33 k	$687.51 mm	+9.5%

Largest transactions	Shares	Bought/sold	Change
Solel Partners	0.00	-4.58 mm	EXIT
Ardsley Advisory Partners	0.00	-1.73 mm	EXIT
Polar Capital	0.00	-1.25 mm	EXIT
Uniplan Investment Counsel	0.00	-458.22 k	EXIT
Fourth Sail Capital	1.96 mm	+334.20 k	+20.5%
Ballast Asset Management	0.00	-298.12 k	EXIT
Royce & Associates	0.00	-287.87 k	EXIT
Wellington Management	0.00	-245.03 k	EXIT
Long Focus Capital Management	0.00	-233.90 k	EXIT
Tudor Investment Corp Et Al	0.00	-140.50 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Oppenheimer Maintains Outperform on Bioceres Crop Solutions, Lowers Price Target to $12

Oppenheimer analyst Kristen Owen maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Outperform and lowers the price target from $13 to $12.

A Closer Look at 7 Analyst Recommendations For Bioceres Crop Solutions

Canaccord Genuity Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $9.5

Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $10 to $9.5.

Bioceres Crop Solutions Q1 Sales $93.300 Miss $109.250M Estimate, Net Loss $5.3M Up From $2.7M YoY

Earnings Scheduled For November 11, 2024

Press releases

From Benzinga Pro

Bioceres Crop Solutions to Host Fiscal Second Quarter 2025 Financial Results Conference Call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops

Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results

Total revenues in 1Q25 were $93.3 million 1Q25 net loss1 was $5.3 million and Adjusted EBITDA1 was $8.5 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.